This brief details the strong body of evidence and experience with self-injection of DMPA-SC in low-resource settings, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.
- HCDExchange
- 5
- Resource LIBRARY
- 5
- Self-injected subcutaneous DMPA: A new frontier in advancing contraceptive access and use for women.
Self-injected subcutaneous DMPA: A new frontier in advancing contraceptive access and use for women.
Publication Year: 2019
Contributing Organisation: PATH
Authors: Melanie Punton, Emma Mulhern, Gabrielle Appleford
Learning Themes: Global Health